Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Scott Cramer to Hyperoxaluria, Primary

This is a "connection" page, showing publications Scott Cramer has written about Hyperoxaluria, Primary.

 
Connection Strength
 
 
 
0.992
 
  1. Takayama T, Nagata M, Ozono S, Nonomura K, Cramer SD. A novel mutation in the GRHPR gene in a Japanese patient with primary hyperoxaluria type 2. Nephrol Dial Transplant. 2007 Aug; 22(8):2371-4.
    View in: PubMed
    Score: 0.289
  2. Knight J, Holmes RP, Milliner DS, Monico CG, Cramer SD. Glyoxylate reductase activity in blood mononuclear cells and the diagnosis of primary hyperoxaluria type 2. Nephrol Dial Transplant. 2006 Aug; 21(8):2292-5.
    View in: PubMed
    Score: 0.267
  3. Webster KE, Ferree PM, Holmes RP, Cramer SD. Identification of missense, nonsense, and deletion mutations in the GRHPR gene in patients with primary hyperoxaluria type II (PH2). Hum Genet. 2000 Aug; 107(2):176-85.
    View in: PubMed
    Score: 0.180
  4. Webster KE, Cramer SD. Genetic basis of primary hyperoxaluria type II. Mol Urol. 2000; 4(4):355-64.
    View in: PubMed
    Score: 0.173
  5. Levin-Iaina N, Dinour D, Romero L, Ron R, Brady RL, Cramer SD, Holtzman EJ. Late diagnosis of primary hyperoxaluria type 2 in the adult: effect of a novel mutation in GRHPR gene on enzymatic activity and molecular modeling. J Urol. 2009 May; 181(5):2146-51.
    View in: PubMed
    Score: 0.082
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)